SCHEMBL27930130

SCHEMBL27930130

NC(=O)c1ccc(Cl)c2cccnc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.59
KMT2A Q03164 3/20 0.59
ATM Q13315 1/20 0.59
HSP90AA1 P07900 3/20 0.57
MAPT P10636 3/20 0.57
LMNA P02545 2/20 0.57
BRD4 O60885 1/20 0.57
METAP2 P50579 1/20 0.57
METAP1 P53582 1/20 0.57
PARP1 P09874 1/20 0.56
RPS6KB1 P23443 4/20 0.55
CYP3A4 P08684 2/20 0.54
ALOX12 P18054 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689718 0.87 PARP1 (0.56) KDM4EKMT2AATMHSP90AA1MAPT
SCHEMBL28507152 0.85 KDM4E (0.59) KDM4EKMT2AHSP90AA1MAPTLMNA
SCHEMBL15053947 0.81 KDM4E (0.61) KDM4EKMT2AHSP90AA1MAPTBRD4
SCHEMBL29448814 0.80 KDM4E (0.59) KDM4EHSP90AA1PARP1RPS6KB1HTT
SCHEMBL27767795 0.80 KDM4E (0.64) KDM4EPARP1RPS6KB1L3MBTL1
SCHEMBL20515237 0.80 KDM4E (0.59) KDM4EKMT2AHSP90AA1MAPTPARP1
SCHEMBL18979963 0.79 PARP1 (0.49) KDM4EKMT2AATMPARP1RPS6KB1
SCHEMBL27947200 0.76 RPS6KB1 (0.58) KDM4EPARP1RPS6KB1L3MBTL1
SCHEMBL196536 0.76 KDM4E (0.70) KDM4EKMT2AHSP90AA1MAPTLMNA
SCHEMBL6218744 0.75 KDM4E (0.52) KDM4EKMT2AHSP90AA1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103492028-A Novel sulfonaminoquinoline hepcidin antagonists VIFOR INT AG 2014-01-01 CN disclosed